Companies
Zoetis
S&P 500Health Care· USA

ZTS

Status-Quo-Player

Zoetis

$120.08

+1.91%

Open $117.17·Prev $117.83

as of 13 Apr

STATUS-QUO-PLAYER

Power Core

The moat in one sentence: Zoetis's power derives from the compounding interaction between its direct-to-veterinarian sales network and a continuously refreshed product portfolio that creates switching costs at the point of prescribing, not at the point of chemistry.

Published1 Apr 2026
UniverseS&P 500
SectorHealth Care

Direction of Movement

Upward, Driven by Novel Biologics and Distribution Flywheel

ROC 200

-28.3%

This page is for informational purposes only and does not constitute investment advice. L17X Research is an independent research service.
ZTS — Zoetis — Power Mapping Analysis — L17X — L17X